Education
About Us
Working with TipRanks
Follow Us
Zealand Pharma (ZLDPF)
OTHER OTC:ZLDPF
ZLDPF Stock Chart & Stats
Day’s Range― - ―
52-Week Range$71.20 - $141.74
Previous CloseN/A
Volume19.00
Average Volume (3M)721.00
Market Cap
$5.78B
Enterprise Value$42.72B
Total Cash (Recent Filing)kr672.39M
Total Debt (Recent Filing)kr389.18M
Price to Earnings (P/E)―
Beta1.08
Next Earnings
May 08, 2025EPS Estimate
-0.32Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-2.36
Shares Outstanding71,023,870
10 Day Avg. Volume1,441
30 Day Avg. Volume721
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)364.46
Price to Cash Flow (P/CF)-37.20
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
$123.23Price Target Upside49.70% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering6
---
Ownership Overview
―
Insiders
18.42% Mutual Funds
― Other Institutional Investors
74.99% Public Companies and
Individual Investors
Risk Analysis
Main Risk Category
Tech & InnovationRisks related to the company’s reliance on technology and ability to make innovative products
ZLDPF FAQ
What was Zealand Pharma’s price range in the past 12 months?
Zealand Pharma lowest stock price was $71.20 and its highest was $141.74 in the past 12 months.
What is Zealand Pharma’s market cap?
Zealand Pharma’s market cap is $5.78B.
When is Zealand Pharma’s upcoming earnings report date?
Zealand Pharma’s upcoming earnings report date is May 08, 2025 which is in 45 days.
How were Zealand Pharma’s earnings last quarter?
Zealand Pharma released its earnings results on Feb 20, 2025. The company reported -$0.597 earnings per share for the quarter, beating the consensus estimate of -$0.745 by $0.149.
Is Zealand Pharma overvalued?
According to Wall Street analysts Zealand Pharma’s price is currently Undervalued.
Does Zealand Pharma pay dividends?
Zealand Pharma does not currently pay dividends.
What is Zealand Pharma’s EPS estimate?
Zealand Pharma’s EPS estimate is -0.32.
How many shares outstanding does Zealand Pharma have?
Zealand Pharma has 71,023,870 shares outstanding.
What happened to Zealand Pharma’s price movement after its last earnings report?
Zealand Pharma reported an EPS of -$0.597 in its last earnings report, beating expectations of -$0.745. Following the earnings report the stock price went down -1.61%.
Which hedge fund is a major shareholder of Zealand Pharma?
Currently, no hedge funds are holding shares in ZLDPF
---
Company Description
Zealand Pharma
Zealand Pharma A/S is a biotechnology company that engages in the discovery, design and development of peptide based medicines. Its products include Soliqua and Lyxumia. The company was founded by Lars Hellerung Christiansen and Bjarne Due Larsen on October 19, 1998 and is headquartered in Glostrup, Denmark.
---
ZLDPF Company Deck
---
ZLDPF Earnings Call
Q4 2025
0:00 / 0:00
Earnings Call Sentiment|Positive
The earnings call reflected a positive sentiment overall, with significant advancements in clinical trials and a strong financial position. However, challenges such as regulatory setbacks and partnership uncertainties were noted.Read More>---
ZLDPF Stock 12 Month Forecast
Average Price Target
$123.23
▲(49.70% Upside)
Technical Analysis
RedHill Biopharma
―
Verastem
―
MannKind
―
Outlook Therapeutics
―
Bristol-Myers Squibb
―
Pfizer
―
Best Analysts Covering ZLDPF
1 Year
1 Year Success Rate
2/5 ratings generated profit
1 Year Average Return
+26.22%
reiterated a buy rating 7 months ago
Copying Rajan Sharma's trades and holding each position for 1 Year would result in 40.00% of your transactions generating a profit, with an average return of +26.22% per trade.
---